BioNTech Se (BNTX) Q1 2024 Earnings Call Transcript
BNTX earnings call for the period ending March 31, 2024.
Source: fool.com
Stay updated with breaking news from Yaron Werber. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BNTX earnings call for the period ending March 31, 2024.
Genmab A/S reports earnings inline with expectations. Reported EPS is $0.16 EPS, expectations were $0.16.
EXEL earnings call for the period ending March 31, 2024.
Roivant Sciences Ltd. misses on earnings expectations. Reported EPS is $-0.3 EPS, expectations were $-0.27. Roivant Sciences Ltd.
SpringWorks Therapeutics' drug for treating adult patients with a type of rare noncancerous soft-tissue tumor will be sold in the US at a list price of $29,000 for a 30-day supply.